ArticleInflammation2025
Aberrant Subsets of Regulatory T Cells and their Correlations with Serum IL-2 in Patients with Rheumatoid Arthritis.
Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Oral-Gut-Immune-Nutrition Axis in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic Implications.International journal of molecular sciences · 2026Review
- Physical Fitness Dynamics Shape Immune Remodeling in Healthy Aging: A 3-Year Longitudinal Study.Aging cell · 2026Article
- Immunological dysregulation of follicular helper T cells, follicular regulatory T cells, and follicular cytotoxic T cells is associated with disease activity and identifies exploratory immune patterns in rheumatoid arthritis.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Aberrant number and/or dysfunction of regulatory T cells (Tregs) is associated with the development of rheumatoid arthritis (RA). This study aimed to assess the frequencies of naive Tregs (nTregs) and memory Tregs (mTregs) in the peripheral blood of RA patients and to explore their relationships with cytokine levels. This study involved 97 RA patients categorized into three groups based on Disease Activity Score 28 (DAS28) and 50 healthy controls (HCs). Flow cytometry was employed to quantify Treg subsets in peripheral blood, while serum cytokine concentrations were measured using a flow cytometry bead array. The findings revealed that three RA groups, stratified by disease activity, all exhibited a significant decrease in both the count and percentage of nTregs and an increase in the percentage of mTregs compared to HCs. Notably, the group with high RA disease activity displayed a higher percentage of mTregs than the remission group. Additionally, correlation analysis indicated that IL-2 concentrations were negatively correlated with total T, CD4 + T and Th17 cell counts, and positively correlated with the absolute count of nTregs. This study demonstrated that the count of mTregs in RA patients increased with escalating disease activity, while the count of nTregs remained unchanged. Moreover, IL-2 concentrations were positively correlated with the numbers of Tregs and nTregs, suggesting that IL-2 plays a significant role in modulating Treg subsets. Further studies on targeted therapies aligned with the distribution of mTregs and nTregs in RA patients with varying disease activity could potentially achieve effective remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.